Profile picture of Dr. Deborah C. Holt

Infectious Disease Specialist

Australian Flag

Deborah C. Holt

Icon representing available degree

PhD; Bachelor of Applied Science; Graduate Diploma

Icon that representing available experience

33 Years Overall Experience

Icon representing available city of this doctor

Darwin

Connect with Deborah C. Holt

Quick Appointment for Deborah C. Holt

No OPD information available

Services Offered by Deborah C. Holt

  • Scabies

  • Impetigo

  • Poststreptococcal Glomerulonephritis

  • Rhabditida Infections

  • Strongyloidiasis

  • Methicillin-Resistant Staphylococcus Aureus (MRSA)

  • Rheumatic Fever

  • Secernentea Infections

  • Streptococcal Group A Infection

  • Chlamydia

  • Glomerulonephritis

  • Head Lice

  • Helminthiasis

  • Strep Throat

About Of Deborah C. Holt

Deborah C. Holt is a female healthcare provider who helps patients with various health issues such as scabies, impetigo, strep throat, and more. She is skilled in treating infections caused by bacteria and parasites like MRSA and head lice. Holt also specializes in conditions like glomerulonephritis and rheumatic fever.

Patients trust Deborah C. Holt because she communicates clearly and listens to their concerns. She explains medical information in a way that is easy to understand, making patients feel comfortable and informed about their health.

To stay updated with the latest medical knowledge, Deborah C. Holt regularly reads research articles and attends conferences. This helps her provide the best possible care for her patients and ensures she is using the most effective treatments available.

Deborah C. Holt works well with her colleagues and other medical professionals. She values teamwork and collaboration, which leads to better outcomes for patients. By sharing knowledge and expertise with others in the medical field, Holt contributes to a supportive and effective healthcare environment.

Holt's dedication to her work has had a positive impact on many patients' lives. Through her expertise and compassionate care, she has helped improve the health and well-being of those she treats. Her commitment to providing quality healthcare services has earned her respect and gratitude from her patients and colleagues.

One of Deborah C. Holt's notable publications is "Correction: Scabies Mite Peritrophins Are Potential Targets of Human Host Innate Immunity," published in PLoS neglected tropical diseases on July 11, 2024. This research highlights her contribution to advancing medical knowledge and improving treatments for infectious diseases.

Deborah C. Holt's commitment to patient care, continuous learning, collaboration with colleagues, and impactful research make her a trusted and respected healthcare provider who positively impacts the lives of those she serves.

Education of Deborah C. Holt

  • Bachelor of Applied Science; Royal Melbourne Institute of Technology; 1992

  • PhD; University of Sydney; 2000

  • Graduate Diploma in Information Technology; University of Southern Queensland; 2009

Memberships of Deborah C. Holt

  • Member of the Australian Society for Parasitology (ASP)

Experience of Deborah C. Holt

  • Honorary Senior Research Fellow, Menzies School of Health Research, Darwin, Australia (current; focuses on molecular epidemiology, pathogen genomics, and diagnostics for infectious diseases like scabies and streptococcal infections in tropical/Indigenous communities).

  • Senior Lecturer in Biomedical Sciences, Charles Darwin University, Darwin, Australia (current; involved in teaching, PhD supervision, and research in bacterial/parasitic pathogens).

Publications by Deborah C. Holt

Temporal and geographical lineage dynamics of invasive Streptococcus pyogenes in Australia from 2011 to 2023: a retrospective, multicentre, clinical and genomic epidemiology study.

Journal: The Lancet. Microbe
Year: April 17, 2024
Authors: Ouli Xie, Rebecca Chisholm, Leo Featherstone, An N Nguyen, Andrew Hayes, Magnus Jespersen, Cameron Zachreson, Nefel Tellioglu, Gerry Tonkin Hill, Ravindra Dotel, Stephanie Spring, Alice Liu, Alexander Rofe, Sebastian Duchene, Norelle Sherry, Robert Baird, Vicki Krause, Deborah Holt, Lachlan J Coin, Neela Rai, Matthew O'sullivan, Katherine Bond, Jukka Corander, Benjamin Howden, Tony Korman, Bart Currie, Steven Y Tong, Mark Davies

Description:Background: Defining the temporal dynamics of invasive Streptococcus pyogenes (group A Streptococcus) and differences between hyperendemic and lower-incidence regions provides crucial insights into pathogen evolution and, in turn, informs preventive measures. We aimed to examine the clinical and temporal lineage dynamics of S pyogenes across different disease settings in Australia to improve understanding of drivers of pathogen diversity. Methods: In this retrospective, multicentre, clinical and genomic epidemiology study, we identified cases of invasive S pyogenes infection from normally sterile sites between Jan 1, 2011, and Feb 28, 2023. Data were collected from five hospital networks across low-incidence regions in temperate southeast Australia and the hyperendemic, tropical, and largely remote Top End of the Northern Territory of Australia. The crude incidence rate ratio (IRR) of bloodstream S pyogenes infection comparing the Top End and southeast Australia and in First Nations people compared with non-First Nations people was estimated by quasi-Poisson regression. We estimated odds ratios (ORs) of intensive care unit (ICU) admission, in-hospital mortality, and 30-day mortality for the Top End versus southeast Australia using logistic regression. Retrieved and successfully sequenced isolates were assigned lineages at whole-genome resolution. Temporal trends in the composition of co-circulating lineages were compared between the two regions. We used an S pyogenes-specific multistrain simulated transmission model to examine the relationship between host population-specific parameters and observed pathogen lineage dynamics. The prevalence of accessory genes (those present in 5-95% of all genomes) was compared across geographies and temporal periods to investigate genomic drivers of diversity. Results: We identified 500 cases of invasive S pyogenes infection in patients in the Top End and 495 cases in patients in southeast Australia. The crude IRR of bloodstream infection for the Top End compared with southeast Australia was 5·97 (95% CI 4·61-7·73) across the entire study period; in the Top End, infection disproportionately affected First Nations people compared with non-First Nations people (5·41, 4·28-6·89). The odds of in-hospital mortality (OR 0·43, 95% CI 0·26-0·70), 30-day mortality (0·38, 0·23-0·63), and ICU admission (0·42, 0·30-0·59) were lower in the Top End than in southeast Australia. Longitudinal lineage analysis of 642 S pyogenes genomes identified waves of replacement with distinct lineages in the Top End, whereas southeast Australia had a small number of dominant lineages that persisted and cycled in frequency. The transmission model qualitatively reproduced a similar pattern of replacement with distinct lineages when using a high transmission rate, small population size, and high levels of human movement-characteristics similar to those of communities in the hyperendemic Top End. Using a lower transmission rate, larger population size, and lower levels of migration similar to those of communities in urbanised southeast Australia, the transmission model qualitatively reproduced a pattern of dominant lineages that cycled in frequency. Despite distinct circulating lineages, the prevalence of accessory genes in the bacterial population was maintained across geographies and temporal periods. Conclusions: In a hyperendemic setting, the replacement of distinct S pyogenes lineages occurred in waves, which could be linked to the disproportionate burden of disease and sparse human population in this setting. The maintenance of bacterial gene frequency could be consistent with multilocus selection. These findings suggest that lineage-specific interventions-such as vaccines under development-should consider disease setting and, without broad cross-protection, might lead to lineage replacement. Background: National Health and Medical Research Council, and Leducq Foundation.

Overlapping Streptococcus pyogenes and Streptococcus dysgalactiae subspecies equisimilis household transmission and mobile genetic element exchange.

Journal: Nature Communications
Year: January 12, 2024
Authors: Ouli Xie, Cameron Zachreson, Gerry Tonkin Hill, David Price, Jake Lacey, Jacqueline Morris, Malcolm Mcdonald, Asha Bowen, Philip Giffard, Bart Currie, Jonathan Carapetis, Deborah Holt, Stephen Bentley, Mark Davies, Steven Y Tong

Description:Streptococcus dysgalactiae subspecies equisimilis (SDSE) and Streptococcus pyogenes share skin and throat niches with extensive genomic homology and horizontal gene transfer (HGT) possibly underlying shared disease phenotypes. It is unknown if cross-species transmission interaction occurs. Here, we conduct a genomic analysis of a longitudinal household survey in remote Australian First Nations communities for patterns of cross-species transmission interaction and HGT. Collected from 4547 person-consultations, we analyse 294 SDSE and 315 S. pyogenes genomes. We find SDSE and S. pyogenes transmission intersects extensively among households and show that patterns of co-occurrence and transmission links are consistent with independent transmission without inter-species interference. We identify at least one of three near-identical cross-species mobile genetic elements (MGEs) carrying antimicrobial resistance or streptodornase virulence genes in 55 (19%) SDSE and 23 (7%) S. pyogenes isolates. These findings demonstrate co-circulation of both pathogens and HGT in communities with a high burden of streptococcal disease, supporting a need to integrate SDSE and S. pyogenes surveillance and control efforts.

An outbreak of acute rheumatic fever in a remote Aboriginal community.

Journal: Australian And New Zealand Journal Of Public Health
Year: January 30, 2023
Authors: Natasha Egoroff, Hilary Bloomfield, Wanamula Gondarra, Brando Yambalpal, Terrence Guyula, Demi Forward, Gemma Lyons, Emer O'connor, Lou Sanderson, Michelle Dowden, Desley Williams, Jessica De Dassel, Pasqualina Coffey, Elizabeth Dhurrkay, Veronica Gondarra, Deborah Holt, Vicki Krause, Bart Currie, Kalinda Griffiths, Karen Dempsey, Anna Glynn Robinson

Description:Objective: We describe the public health response to an outbreak of acute rheumatic fever (ARF) in a remote Aboriginal community. Methods: In August 2021, the Northern Territory Rheumatic Heart Disease Control Program identified an outbreak of acute rheumatic fever in a remote Aboriginal community. A public health response was developed using a modified acute poststreptococcal glomerulonephritis protocol and the National Acute Rheumatic Fever Guideline for Public Health Units. Results: 12 cases were diagnosed during the outbreak; six-times the average number of cases in the same period in the five years prior (n=1.8). Half (n=6) of the outbreak cases were classified as recurrent episodes with overdue secondary prophylaxis. Contact tracing and screening of 11 households identified 86 close contacts. Conclusions: This outbreak represented an increase in both first episodes and recurrences of acute rheumatic fever and highlights the critical need for strengthened delivery of acute rheumatic fever secondary prophylaxis, and for improvements to the social determinants of health in the region. Conclusions: Outbreaks of acute rheumatic fever are rare despite continuing high rates of acute rheumatic fever experienced by remote Aboriginal communities. Nevertheless, there can be improvements in the current national public health guidance relating to acute rheumatic fever cluster and outbreak management.

Frequently Asked Questions About Deborah C. Holt

What conditions does Deborah C. Holt, Infectious Disease Specialist, commonly treat?

Deborah C. Holt specializes in treating a wide range of infectious diseases such as HIV/AIDS, tuberculosis, influenza, and various bacterial infections.

What services does Deborah C. Holt offer for patients with infectious diseases?

Deborah C. Holt provides comprehensive evaluations, diagnostic testing, treatment plans, and ongoing management for patients with infectious diseases.

How can I schedule an appointment with Deborah C. Holt, Infectious Disease Specialist?

To schedule an appointment with Deborah C. Holt, you can contact her office directly or request a referral from your primary care physician.

What should I do if I suspect I have been exposed to a contagious illness or infection?

If you suspect you have been exposed to a contagious illness or infection, it is important to seek medical attention promptly. Contact Deborah C. Holt's office for guidance on next steps.

Are telemedicine consultations available with Deborah C. Holt for infectious disease concerns?

Yes, Deborah C. Holt offers telemedicine consultations for certain infectious disease concerns, providing convenient access to care for patients.

How can I best protect myself and prevent the spread of infectious diseases in my community?

Deborah C. Holt can provide guidance on preventive measures such as vaccinations, proper hygiene practices, and lifestyle modifications to help protect yourself and others from infectious diseases.

More Infectious Disease Specialist Like Deborah C. Holt in Darwin

Toparrow